Vollmer, B. L., Nair, K., Sillau, S., Corboy, J. R., Vollmer, T., & Alvarez, E. (2020). Rituximab versus natalizumab, fingolimod, and dimethyl fumarate in multiple sclerosis treatment. Ann Clin Transl Neurol.
シカゴスタイル引用形Vollmer, Brandi L., Kavita Nair, Stefan Sillau, John R. Corboy, Timothy Vollmer, , Enrique Alvarez. "Rituximab Versus Natalizumab, Fingolimod, and Dimethyl Fumarate in Multiple Sclerosis Treatment." Ann Clin Transl Neurol 2020.
MLA引用形式Vollmer, Brandi L., et al. "Rituximab Versus Natalizumab, Fingolimod, and Dimethyl Fumarate in Multiple Sclerosis Treatment." Ann Clin Transl Neurol 2020.
警告: この引用は必ずしも正確ではありません.